Works matching AU Eggermont, Alexander

Results: 139

Serum concentrations of pegylated interferon alpha-2b in patients with resected stage III melanoma receiving adjuvant pegylated interferon alpha-2b in a randomized phase III trial (EORTC 18991).

Published in:

2010

By:

Eggermont AM;
Bouwhuis MG;
Kruit WH;
Testori A;
ten Hagen T;
Yver A;
Xu C;
Eggermont, Alexander M M;
Bouwhuis, Marna G;
Kruit, Wim H;
Testori, Alessandro;
ten Hagen, Timo;
Yver, Antoine;
Xu, Christine

Publication type:

journal article

Serum concentrations of pegylated interferon α-2b in patients with resected stage III melanoma receiving adjuvant pegylated interferon α-2b in a randomized phase III trial (EORTC 18991).

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 4, p. 671, doi. 10.1007/s00280-009-1072-z

By:

Eggermont, Alexander M. M.;
Bouwhuis, Marna G.;
Kruit, Wim H.;
Testori, Alessandro;
ten Hagen, Timo;
Yver, Antoine;
Xu, Christine

Publication type:

Article

Nitric oxide production and monoamine oxidase activity in cancer patients during interferon-α therapy.

Published in:

Amino Acids, 2009, v. 37, n. 4, p. 703

By:

Marjolein Bannink;
Stefan Sleijfer;
Wim Kruit;
Bronno van der Holt;
Alexander Eggermont;
Michiel Hengeveld;
Gerrit Stoter

Publication type:

Article

The Emerging Role of Cytokines in the Treatment of Advanced Melanoma.

Published in:

Oncology, 2000, v. 58, n. 2, p. 89, doi. 10.1159/000012085

By:

Keilholz, Ulrich;
Eggermont, Alexander M.M.

Publication type:

Article

Rat interleukin-2-activated natural killer (A-NK) cell-mediated lysis is determined by the presence of CD18 on A-NK cells and the absence of major histocompatibility complex class I on target cells.

Published in:

European Journal of Immunology, 1994, v. 24, n. 1, p. 171, doi. 10.1002/eji.1830240126

By:

Smits, Katinka M.;
Kuppen, Peter J. K.;
Eggermont, Alexander M. M.;
Tamatani, Takuya;
Miyasaka, Masayuki;
Fleuren, Gert Jan

Publication type:

Article

Influence of microbiota-associated metabolic reprogramming on clinical outcome in patients with melanoma from the randomized adjuvant dendritic cell-based MIND-DC trial.

Published in:

Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45357-1

By:

Alves Costa Silva, Carolina;
Piccinno, Gianmarco;
Suissa, Déborah;
Bourgin, Mélanie;
Schreibelt, Gerty;
Durand, Sylvère;
Birebent, Roxanne;
Fidelle, Marine;
Sow, Cissé;
Aprahamian, Fanny;
Manghi, Paolo;
Punčochář, Michal;
Asnicar, Francesco;
Pinto, Federica;
Armanini, Federica;
Terrisse, Safae;
Routy, Bertrand;
Drubay, Damien;
Eggermont, Alexander M. M.;
Kroemer, Guido

Publication type:

Article

Strategies to decrease inequalities in cancer therapeutics, care and prevention: Proceedings on a conference organized by the Pontifical Academy of Sciences and the European Academy of Cancer Sciences, Vatican City, February 23–24, 2023.

Published in:

Molecular Oncology, 2024, v. 18, n. 2, p. 245, doi. 10.1002/1878-0261.13575

By:

Ringborg, Ulrik;
von Braun, Joachim;
Celis, Julio;
Baumann, Michael;
Berns, Anton;
Eggermont, Alexander;
Heard, Edith;
Heitor, Manuel;
Chandy, Mammen;
Chen, Chien‐Jen;
Costa, Alberto;
De Lorenzo, Francesco;
De Robertis, Edward M.;
Dubee, Frederick Charles;
Ernberg, Ingemar;
Gabriel, Mariya;
Helland, Åslaug;
Henrique, Rui;
Jönsson, Bengt;
Kallioniemi, Olli

Publication type:

Article

Engaging European society at the forefront of cancer research and care: How discussions at the 5<sup>th</sup> Gago Conference on European Science policy led to the Heidelberg Manifesto.

Published in:

Molecular Oncology, 2023, v. 17, n. 6, p. 925, doi. 10.1002/1878-0261.13423

By:

Baumann, Michael;
Celis, Julio;
Ringborg, Ulrik;
Heitor, Manuel;
Berns, Anton;
Albreht, Tit;
Arabadjiev, Jeliazko;
Boutros, Michael;
Brandenburg, Mario;
Canhao, Helena;
Carneiro, Fatima;
Chomienne, Christine;
De Lorenzo, Francesco;
Eggermont, Alexander M. M.;
Font, Angel;
Garralda, Elena;
Goulart, Margarida;
Henrique, Rui;
Lawler, Mark;
Maier‐Hein, Lena

Publication type:

Article

Towards a cancer mission in Horizon Europe: recommendations.

Published in:

Molecular Oncology, 2020, v. 14, n. 8, p. 1589, doi. 10.1002/1878-0261.12763

By:

Berns, Anton;
Ringborg, Ulrik;
Celis, Julio E.;
Heitor, Manuel;
Aaronson, Neil K.;
Abou‐Zeid, Nancy;
Adami, Hans‐Olov;
Apostolidis, Kathi;
Baumann, Michael;
Bardelli, Alberto;
Bernards, René;
Brandberg, Yvonne;
Caldas, Carlos;
Calvo, Fabien;
Dive, Caroline;
Eggert, Angelika;
Eggermont, Alexander;
Espina, Carolina;
Falkenburg, Frederik;
Foucaud, Jérôme

Publication type:

Article

Towards a Cancer Mission in Horizon Europe.

Published in:

Molecular Oncology, 2019, v. 13, n. 11, p. 2301, doi. 10.1002/1878-0261.12585

By:

Berns, Anton;
Ringborg, Ulrik;
Eggermont, Alexander;
Baumann, Michael;
Calvo, Fabien;
Eggert, Angelika;
Espina, Carolina;
Hanahan, Douglas;
Lacombe, Denis;
Lorenzo, Francesco;
Oberst, Simon;
Philip, Thierry;
Schüz, Joachim;
Tabernero, Josep;
Celis, Julio E.

Publication type:

Article

Boosting the social impact of innovative cancer research – towards a mission‐oriented approach to cancer.

Published in:

Molecular Oncology, 2019, v. 13, n. 3, p. 497, doi. 10.1002/1878-0261.12464

By:

Ringborg, Ulrik;
Celis, Julio E.;
Baumann, Michael;
Eggermont, Alexander;
Wild, Christopher P.;
Berns, Anton

Publication type:

Article

Cancer Core Europe: A translational research infrastructure for a European mission on cancer.

Published in:

Molecular Oncology, 2019, v. 13, n. 3, p. 521, doi. 10.1002/1878-0261.12447

By:

Eggermont, Alexander M. M.;
Apolone, Giovanni;
Baumann, Michael;
Caldas, Carlos;
Celis, Julio E.;
Lorenzo, Francesco;
Ernberg, Ingemar;
Ringborg, Ulrik;
Rowell, John;
Tabernero, Josep;
Voest, Emile;
Calvo, Fabien

Publication type:

Article

European Academy of Cancer Sciences – position paper.

Published in:

Molecular Oncology, 2018, v. 12, n. 11, p. 1829, doi. 10.1002/1878-0261.12379

By:

Adami, Hans‐Olov;
Berns, Anton;
Celis, Julio E.;
Vries, Elisabeth;
Eggermont, Alexander;
Harris, Adrian;
zur Hausen, Harald;
Pelicci, Pier Giuseppe;
Ringborg, Ulrik

Publication type:

Article

The challenge to bring personalized cancer medicine from clinical trials into routine clinical practice: The case of the Institut Gustave Roussy

Published in:

Molecular Oncology, 2012, v. 6, n. 2, p. 204, doi. 10.1016/j.molonc.2012.02.008

By:

Arnedos, Monica;
André, Fabrice;
Farace, Françoise;
Lacroix, Ludovic;
Besse, Benjamin;
Robert, Caroline;
Soria, Jean Charles;
Eggermont, Alexander M.M.

Publication type:

Article

Immunologic functions as prognostic indicators in melanoma

Published in:

Molecular Oncology, 2011, v. 5, n. 2, p. 183, doi. 10.1016/j.molonc.2011.01.004

By:

Bouwhuis, Marna G.;
ten Hagen, Timo L.M.;
Eggermont, Alexander M.M.

Publication type:

Article

Melanoma – The pieces of the puzzle finally start coming together!

Published in:

2011

By:

Spatz, Alan;
Eggermont, Alexander M.M.

Publication type:

Editorial

PD-Loma: a cancer entity with a shared sensitivity to the PD-1/PD-L1 pathway blockade.

Published in:

2019

By:

Hirsch, Laure;
Zitvogel, Laurence;
Eggermont, Alexander;
Marabelle, Aurelien

Publication type:

Editorial

Future perspectives in melanoma research. Meeting report from the "Melanoma Bridge. Napoli, December 2nd-4th 2012".

Published in:

Journal of Translational Medicine, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-137

By:

Ascierto, Paolo A.;
Grimaldi, Antonio M.;
Acquavella, Nicolas;
Borgognoni, Lorenzo;
Calabrò, Luana;
Cascinelli, Natale;
Cesano, Alessandra;
Del Vecchio, Michele;
Eggermont, Alexander M;
Faries, Mark;
Ferrone, Soldano;
Fox, Bernard A.;
Gajewski, Thomas F.;
Galon, Jérôme;
Gnjatic, Sacha;
Gogas, Helen;
Kashani-Sabet, Mohammed;
Kaufman, Howard L.;
Larkin, James;
Lo, Roger S.

Publication type:

Article

Integration of Translational Research in the European Organization for Research and Treatment of Cancer Research (EORTC) Clinical Trial Cooperative Group Mechanisms.

Published in:

Journal of Translational Medicine, 2003, v. 1, p. 2, doi. 10.1186/1479-5876-1-2

By:

Lehmann, Frederic;
Lacombe, Denis;
Therasse, Patrick;
Eggermont, Alexander M. M.

Publication type:

Article

MANIPULATION OF THE TUMOUR-ASSOCIATED VASCULATURE TO IMPROVE TUMOUR THERAPY.

Published in:

Journal of Liposome Research, 2002, v. 12, n. 1/2, p. 149, doi. 10.1081/LPR-120004788

By:

ten Hagen, Timo L. M.;
Eggermont, Alexander M. M.

Publication type:

Article

Shifting landscape in skin cancer incidence: the rising tide of cutaneous squamous cell carcinoma and potential implications for prevention.

Published in:

British Journal of Dermatology, 2024, v. 190, n. 4, p. 460, doi. 10.1093/bjd/ljad480

By:

Eggermont, Celeste J;
Eggermont, Alexander M M

Publication type:

Article

Reply to ‘Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma’.

Published in:

Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-05048-0

By:

Jacquelot, Nicolas;
Zitvogel, Laurence;
Eggermont, Alexander M.

Publication type:

Article

Optimal pathology of SLN for melanoma.

Published in:

Journal of Pathology, 2003, v. 200, n. 3, p. 314

By:

Martin G Cook;
Margaret A Green;
Brian Anderson;
Alexander MM Eggermont;
Dirk J Ruiter;
Alain Spatz;
Mark W Kissin;
Barry WEM Powell

Publication type:

Article

Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group.

Published in:

Journal of Pathology, 2001, v. 193, n. 1, p. 13, doi. 10.1002/1096-9896(2000)9999:9999<::AID-PATH729>3.0.CO;2-D

By:

de Vries, Teunis J.;
Smeets, Miriam;
de Graaf, Ruurd;
Hou-Jensen, Klaus;
Bröcker, Eva B.;
Renard, Nathalie;
Eggermont, Alexander M. M.;
van Muijen, Goos N. P;
Ruiter, Dirk J.

Publication type:

Article

Enriching lipid nanovesicles with short-chain glucosylceramide improves doxorubicin delivery and efficacy in solid tumors.

Published in:

FASEB Journal, 2011, v. 25, n. 1, p. 280, doi. 10.1096/fj.10-163709

By:

van Lummel, Menno;
van Blitterswijk, Wim J.;
Vink, Stefan R.;
Veldman, Robert Jan;
van der Valk, Martin A.;
Schipper, Debby;
Dicheva, Bilyana M.;
Eggermont, Alexander M. M.;
Hagen, Timo L. M. ten;
Verhelj, Marcel;
Koning, Gerben A.

Publication type:

Article

Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.

Published in:

2016

By:

Ascierto, Paolo A;
Agarwala, Sanjiv;
Botti, Gerardo;
Cesano, Alessandra;
Ciliberto, Gennaro;
Davies, Michael A;
Demaria, Sandra;
Dummer, Reinhard;
Eggermont, Alexander M;
Ferrone, Soldano;
Fu, Yang Xin;
Gajewski, Thomas F;
Garbe, Claus;
Huber, Veronica;
Khleif, Samir;
Krauthammer, Michael;
Lo, Roger S;
Masucci, Giuseppe;
Palmieri, Giuseppe;
Postow, Michael

Publication type:

journal article

Future perspectives in melanoma research.

Published in:

Journal of Translational Medicine, 2016, v. 14, p. 1, doi. 10.1186/s12967-016-1070-y

By:

Ascierto, Paolo A.;
Agarwala, Sanjiv;
Botti, Gerardo;
Cesano, Alessandra;
Ciliberto, Gennaro;
Davies, Michael A.;
Demaria, Sandra;
Dummer, Reinhard;
Eggermont, Alexander M.;
Ferrone, Soldano;
Xin Fu, Yang;
Gajewski, Thomas F.;
Garbe, Claus;
Huber, Veronica;
Khleif, Samir;
Krauthammer, Michael;
Lo, Roger S.;
Masucci, Giuseppe;
Palmieri, Giuseppe;
Postow, Michael

Publication type:

Article

Future perspectives in melanoma research: meeting report from the ''Melanoma Bridge'', Napoli, December 5th-8th 2013.

Published in:

2014

By:

Ascierto, Paolo A.;
Grimaldi, Antonio M.;
Anderson, Ana Carrizosa;
Bifulc, Carlo;
Cochran, Alistair;
Garbe, Claus;
Eggermont, Alexander M.;
Faries, Mark;
Ferrone, Soldano;
Gershenwald, Jeffrey E.;
Gajewski, Thomas F.;
Halaban, Ruth;
Hodi, F. Stephen;
Kefford, Richard;
Kirkwood, John M.;
Larkin, James;
Leachman, Sancy;
Maio, Michele;
Marais, Richard;
Masucci, Giuseppe

Publication type:

Proceeding

Analysis of surrogate gene expression markers in peripheral blood of melanoma patients to predict treatment outcome of adjuvant pegylated interferon alpha 2b (EORTC 18991 side study).

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 7, p. 1223, doi. 10.1007/s00262-013-1428-4

By:

Busse, Antonia;
Rapion, Jérôme;
Fusi, Alberto;
Suciu, Stefan;
Nonnenmacher, Anika;
Santinami, Mario;
Kruit, Wim;
Testori, Alessandro;
Punt, Cornelis;
Dalgleish, Angus;
Spatz, Alan;
Eggermont, Alexander;
Keilholz, Ulrich

Publication type:

Article

Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?

Published in:

Cancer Immunology, Immunotherapy, 2010, v. 59, n. 2, p. 303, doi. 10.1007/s00262-009-0751-2

By:

Bouwhuis, Marna G.;
Gast, Andreas;
Figl, Adina;
Eggermont, Alexander M. M.;
Hemminki, Kari;
Schadendorf, Dirk;
Kumar, Rajiv

Publication type:

Article

Decreased response rates by the combination of histamine and IL-2 in melphalan-based isolated limb perfusion.

Published in:

Cancer Immunology, Immunotherapy, 2007, v. 56, n. 4, p. 573, doi. 10.1007/s00262-006-0206-y

By:

Brunstein, Flavia;
Hoving, Saske;
aan de Wiel-Ambagtsheer, Gisela;
de Bruijn, Ernst A.;
Guetens, Gunther;
Eggermont, Alexander M. M.;
ten Hagen, Timo L. M.

Publication type:

Article

Lack of cell-cycle specific effects of tumor necrosis factor-alpha on tumor cells in vitro: implications for combination tumor therapy with doxorubicin.

Published in:

2002

By:

van der Veen, Alexander H.;
ten Hagen, Timo L. M.;
Seynhaeve, Ann L. B.;
Eggermont, Alexander M. M.

Publication type:

journal article

Intratumoural expression of TNF-R1 and EMAP-II in relation to response of patients treated with TNF-based isolated limb perfusion.

Published in:

International Journal of Cancer, 2006, v. 119, n. 6, p. 1481, doi. 10.1002/ijc.21973

By:

van Horssen, Remco;
Rens, Joost A.P.;
Brunstein, Flavia;
Guns, Veronique;
van Gils, Marjon;
Hagen, Timo L.M. ten;
Eggermont, Alexander M.M.

Publication type:

Article

Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma.

Published in:

International Journal of Cancer, 2005, v. 117, n. 4, p. 596, doi. 10.1002/ijc.21264

By:

Kruit, Wim H.J.;
van Ojik, Heidi H.;
Brichard, Vincent G.;
Escudier, Bernard;
Dorval, Thierry;
Dréno, Brigitte;
Patel, Poulam;
van Baren, Nicolas;
Avril, Marie-Françoise;
Piperno, Sophie;
Khammari, Amir;
Stas, Marguerite;
Ritter, Gerd;
Lethé, Bernard;
Godelaine, Danièle;
Brasseur, Francis;
Zhang, Yi;
van der Bruggen, Pierre;
Boon, Thierry;
Eggermont, Alexander M.M.

Publication type:

Article

Tumor necrosis factor-α augmented tumor response in B16BL6 melanoma-bearing mice treated with stealth liposomal doxorubicin (Doxil®) correlates with altered Doxil® pharmacokinetics.

Published in:

International Journal of Cancer, 2004, v. 109, n. 3, p. 442, doi. 10.1002/ijc.11703

By:

Peter Brouckaert;
Nozomi Takahashi;
Sandra T. van Tiel;
Jeroen Hostens;
Alexander M.M. Eggermont;
Ann L.B. Seynhaeve;
Walter Fiers;
Timo L.M. ten Hagen

Publication type:

Article

A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography.

Published in:

International Journal of Cancer, 2002, v. 102, n. 1, p. 91, doi. 10.1002/ijc.10666

By:

Tilanus-Linthorst, Madeleine;
Verhoog, Leon;
Obdeijn, Inge-Marie;
Bartels, Karina;
Menke-Pluymers, Marian;
Eggermont, Alexander;
Klijn, Jan;
Meijers-Heijboer, Hanne;
van der Kwast, Theo;
Brekelmans, Cecile

Publication type:

Article

Pegylated liposomal tumor necrosis factor-α results in reduced toxicity and synergistic antitumor activity after systemic administration in combination with liposomal doxorubicin (Doxil®) in soft tissue sarcoma-bearing rats.

Published in:

International Journal of Cancer, 2002, v. 97, n. 1, p. 115, doi. 10.1002/ijc.1578

By:

ten Hagen, Timo L.M.;
Seynhaeve, Ann L.B.;
van Tiel, Sandra T.;
Ruiter, Dirk J.;
Eggermont, Alexander M.M.

Publication type:

Article

Low-dose tumor necrosis factor-α augments antitumor activity of stealth liposomal doxorubicin (DOXIL®) in soft tissue sarcoma-bearing rats.

Published in:

International Journal of Cancer, 2000, v. 87, n. 6, p. 829, doi. 10.1002/1097-0215(20000915)87:6<829::AID-IJC12>3.0.CO;2-C

By:

Ten Hagen, Timo L.M.;
Van Der Veen, Alexander H.;
Nooijen, Peet T.G.A.;
Van Tiel, Sandra T.;
Seynhaeve, Ann L.B.;
Eggermont, Alexander M.M.

Publication type:

Article

Angiostatin generation by human tumor cell lines: Involvement of plasminogen activators.

Published in:

International Journal of Cancer, 2000, v. 86, n. 6, p. 760, doi. 10.1002/(SICI)1097-0215(20000615)86:6<760::AID-IJC2>3.0.CO;2-4

By:

Westphal, Johan R.;
Van't Hullenaar, Rianne;
Geurts-Moespot, Anneke;
Sweep, Fred C.J.G.;
Verheijen, Jan H.;
Bussemakers, Marion M.G.;
Askaa, Jon;
Clemmensen, Inge;
Eggermont, Alexander A.M.;
Ruiter, Dirk J.;
De Waal, Robert M.W.

Publication type:

Article

Biodistribution and tumor localization of stealth liposomal tumor necrosis factor-α in soft tissue sarcoma bearing rats.

Published in:

International Journal of Cancer, 1998, v. 77, n. 6, p. 901, doi. 10.1002/(SICI)1097-0215(19980911)77:6<901::AID-IJC17>3.0.CO;2-3

By:

van der Veen, Alexander H.;
Eggermont, Alexander M. M.;
Seynhaeve, Ann L. B.;
van Tiel, Sandra T.;
ten Hagen, Timo L. M.

Publication type:

Article

Regional administration of natural killer cells in a rat hepatic metastasis model results in better tumor infiltration and anti-tumor response than systemic administration.

Published in:

International Journal of Cancer, 1998, v. 75, n. 2, p. 233, doi. 10.1002/(SICI)1097-0215(19980119)75:2<233::AID-IJC11>3.0.CO;2-E

By:

Hagenaars, Martin;
Ensink, N. Geeske;
Koelemij, Ron;
Basse, Per H.;
Eggermont, Alexander M. M.;
van de Velde, Cornelis J. H.;
Fleuren, Gert Jan;
Kuppen, Peter J. K.

Publication type:

Article

Isolated Hypoxic Hepatic Perfusion with Retrograde Outflow in Patients with Irresectable Liver Metastases; A New Simplified Technique in Isolated Hepatic Perfusion.

Published in:

Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2008, v. 15, n. 5, p. 1367, doi. 10.1245/s10434-007-9714-z

By:

Verhoef, Cornelis;
Wilt, Johannes;
Brunstein, Flavia;
Marinelli, Andreas;
Etten, Boudewijn;
Vermaas, Maarten;
Guetens, Gunther;
de Boeck, Gert;
de Bruijn, Ernst;
Eggermont, Alexander

Publication type:

Article

Melanoma Patients with Positive Sentinel Nodes Who Did Not Undergo Completion Lymphadenectomy: A Multi-Institutional Study.

Published in:

Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2006, v. 13, n. 6, p. 809, doi. 10.1245/ASO.2006.03.058

By:

Wong, Sandra;
Morton, Donald;
Thompson, John;
Gershenwald, Jeffrey;
Leong, Stanley;
Reintgen, Douglas;
Gutman, Haim;
Sabel, Michael;
Carlson, Grant;
McMasters, Kelly;
Tyler, Douglas;
Goydos, James;
Eggermont, Alexander;
Nieweg, Omgo;
Cosimi, A.;
Riker, Adam;
G. Coit, Daniel

Publication type:

Article

Efficacy of Repeat Isolated Limb Perfusions With Tumor Necrosis Factor α and Melphalan for Multiple In-Transit Metastases in Patients with Prior Isolated Limb Perfusion Failure.

Published in:

Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2005, v. 12, n. 8, p. 609, doi. 10.1245/ASO.2005.03.060

By:

Grünhagen, Dirk;
Etten, Boudewijn;
Brunstein, Flavia;
Graveland, Wilfried;
Geel, Albertus;
Wilt, Johannes;
Eggermont, Alexander

Publication type:

Article

Isolated Limb Perfusion With Tumor Necrosis Factor and Melphalan Prevents Amputation in Patients With Multiple Sarcomas in Arm or Leg.

Published in:

Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2005, v. 12, n. 6, p. 473, doi. 10.1245/ASO.2005.03.059

By:

Grünhagen, Dirk;
Brunstein, Flavia;
Graveland, Wilfried;
Geel, Albertus;
Wilt, Johannes;
Eggermont, Alexander

Publication type:

Article

Reducing the Need for Sentinel Node Procedures by Ultrasound Examination of Regional Lymph Nodes.

Published in:

2005

By:

Eggermont, Alexander

Publication type:

Editorial

Isolated Hypoxic Hepatic Perfusion With Orthograde or Retrograde Flow in Patients With Irresectable Liver Metastases Using Percutaneous Balloon Catheter Techniques: A Phase I and II Study.

Published in:

Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2004, v. 11, n. 6, p. 598, doi. 10.1245/ASO.2004.09.021

By:

Etten, Boudewijn;
Brunstein, Flavia;
IJken, Marc;
Marinelli, Andreas;
Verhoef, Cornelis;
Sijp, Joost;
Guetens, Gunther;
Boeck, Gert;
Bruijn, Ernst;
Wilt, Johannes;
Eggermont, Alexander

Publication type:

Article

Isolated Limb Perfusion Prolongs the Limb Recurrence-Free Interval After Several Episodes of Excisional Surgery for Locoregional Recurrent Melanoma.

Published in:

Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2004, v. 11, n. 5, p. 491, doi. 10.1245/ASO.2004.04.032

By:

Noorda, Eva;
Takkenberg, Bart;
Vrouenraets, Bart;
Nieweg, Omgo;
Geel, Bert;
Eggermont, Alexander;
Hart, Guus;
Kroon, Bin

Publication type:

Article

Mastectomy by Inverted Drip Incision and Immediate Reconstruction: Data From 510 Cases.

Published in:

Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2003, v. 10, n. 4, p. 389, doi. 10.1245/ASO.2003.07.007

By:

Geel, Albert;
Contant, Caroline;
Wai, Rudi;
Schmitz, Paul;
Eggermont, Alexander;
Menke-Pluijmers, Marian

Publication type:

Article

Fifty Tumor Necrosis Factor–Based Isolated Limb Perfusions for Limb Salvage in Patients Older Than 75 Years With Limb-Threatening Soft Tissue Sarcomas and Other Extremity Tumors.

Published in:

Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2003, v. 10, n. 1, p. 32, doi. 10.1245/ASO.2003.03.076

By:

van Etten, Boudewijn;
van Geel, Albertus;
de Wilt, Johannes;
Eggermont, Alexander

Publication type:

Article